BACKGROUND: Community-associated Staphylococcus aureus infections often affect multiple members of a household. We compared 2 approaches to S. aureus eradication: decolonizing the entire household versus decolonizing the index case alone. METHODS: An open-label, randomized trial enrolled 183 pediatric patients (cases) with community-onset S. aureus skin abscesses and colonization of anterior nares, axillae, or inguinal folds from 2008 to 2009 at primary and tertiary centers. Participants were randomized to decolonization of the case alone (index group) or of all household members (household group). The 5-day regimen included hygiene education, twice-daily intranasal mupirocin, and daily chlorhexidine body washes. Colonization of cases and subsequent skin and soft tissue infection (SSTI) in cases and household contacts were ascertained at 1, 3, 6, and 12 months. RESULTS: Among 147 cases with 1-month colonization data, modified intention-to-treat analysis revealed S. aureus eradication in 50% of cases in the index group and 51% in the household group (P = 1.00). Among 126 cases completing 12-month follow-up, S. aureus was eradicated from 54% of the index group versus 66% of the household group (P = .28). Over 12 months, recurrent SSTI was reported in 72% of cases in the index group and 52% in the household group (P = .02). SSTI incidence in household contacts was significantly lower in the household versus index group during the first 6 months; this trend continued at 12 months. CONCLUSIONS: Household decolonization was not more effective than individual decolonization in eradicating community-associated S. aureus carriage from cases. However, household decolonization reduced the incidence of subsequent SSTI in cases and their household contacts. CLINICAL TRIALS REGISTRATION: NCT00731783.
RCT Entities:
BACKGROUND: Community-associated Staphylococcus aureus infections often affect multiple members of a household. We compared 2 approaches to S. aureus eradication: decolonizing the entire household versus decolonizing the index case alone. METHODS: An open-label, randomized trial enrolled 183 pediatric patients (cases) with community-onset S. aureus skin abscesses and colonization of anterior nares, axillae, or inguinal folds from 2008 to 2009 at primary and tertiary centers. Participants were randomized to decolonization of the case alone (index group) or of all household members (household group). The 5-day regimen included hygiene education, twice-daily intranasal mupirocin, and daily chlorhexidine body washes. Colonization of cases and subsequent skin and soft tissue infection (SSTI) in cases and household contacts were ascertained at 1, 3, 6, and 12 months. RESULTS: Among 147 cases with 1-month colonization data, modified intention-to-treat analysis revealed S. aureus eradication in 50% of cases in the index group and 51% in the household group (P = 1.00). Among 126 cases completing 12-month follow-up, S. aureus was eradicated from 54% of the index group versus 66% of the household group (P = .28). Over 12 months, recurrent SSTI was reported in 72% of cases in the index group and 52% in the household group (P = .02). SSTI incidence in household contacts was significantly lower in the household versus index group during the first 6 months; this trend continued at 12 months. CONCLUSIONS: Household decolonization was not more effective than individual decolonization in eradicating community-associated S. aureus carriage from cases. However, household decolonization reduced the incidence of subsequent SSTI in cases and their household contacts. CLINICAL TRIALS REGISTRATION: NCT00731783.
Authors: Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr Journal: Infect Control Hosp Epidemiol Date: 2003-05 Impact factor: 3.254
Authors: Bradley W Frazee; Jeremy Lynn; Edwin D Charlebois; Larry Lambert; Derrick Lowery; Francoise Perdreau-Remington Journal: Ann Emerg Med Date: 2005-03 Impact factor: 5.721
Authors: Michael W Ellis; Duane R Hospenthal; David P Dooley; Paula J Gray; Clinton K Murray Journal: Clin Infect Dis Date: 2004-09-02 Impact factor: 9.079
Authors: J A Kluytmans; J W Mouton; E P Ijzerman; C M Vandenbroucke-Grauls; A W Maat; J H Wagenvoort; H A Verbrugh Journal: J Infect Dis Date: 1995-01 Impact factor: 5.226
Authors: Trish M Perl; Joseph J Cullen; Richard P Wenzel; M Bridget Zimmerman; Michael A Pfaller; Deborah Sheppard; Jennifer Twombley; Pamela P French; Loreen A Herwaldt Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Patrick G Hogan; Ryan L Mork; Mary G Boyle; Carol E Muenks; John J Morelli; Ryley M Thompson; Melanie L Sullivan; Sarah J Gehlert; Jessica R Merlo; Matt G McKenzie; Juliane Bubeck Wardenburg; Andrey Rzhetsky; Carey-Ann D Burnham; Stephanie A Fritz Journal: J Infect Date: 2018-11-29 Impact factor: 6.072
Authors: Marcela Rodriguez; Patrick G Hogan; Melissa Krauss; David K Warren; Stephanie A Fritz Journal: J Pediatric Infect Dis Soc Date: 2013-02-11 Impact factor: 3.164
Authors: Valerie C Cluzet; Jeffrey S Gerber; Irving Nachamkin; Joshua P Metlay; Theoklis E Zaoutis; Meghan F Davis; Kathleen G Julian; David Royer; Darren R Linkin; Susan E Coffin; David J Margolis; Judd E Hollander; Rakesh D Mistry; Laurence J Gavin; Pam Tolomeo; Jacqueleen A Wise; Mary K Wheeler; Warren B Bilker; Xiaoyan Han; Baofeng Hu; Neil O Fishman; Ebbing Lautenbach Journal: Clin Infect Dis Date: 2015-02-03 Impact factor: 9.079
Authors: J Knox; M Van Rijen; A-C Uhlemann; M Miller; C Hafer; P Vavagiakis; Q Shi; P D R Johnson; G Coombs; M Kluytmans-Van Den Bergh; J Kluytmans; C M Bennett; F D Lowy Journal: Epidemiol Infect Date: 2014-04-24 Impact factor: 2.451
Authors: Carol E Muenks; Whitney C Sewell; Patrick G Hogan; Ryley M Thompson; David G Ross; Jeffrey W Wang; John J Morelli; Sarah J Gehlert; Stephanie A Fritz Journal: J Pediatr Date: 2018-05-11 Impact factor: 4.406
Authors: Katelyn L Parrish; Kristine M Wylie; Patrick J Reich; Patrick G Hogan; Todd N Wylie; Colleen R Kennedy; William Lainhart; David A Hunstad; Carey-Ann D Burnham; Stephanie A Fritz Journal: J Pediatric Infect Dis Soc Date: 2019-11-06 Impact factor: 3.164